摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methyl-(2-methyl-naphth-1-yl)-methylamine | 115600-31-2

中文名称
——
中文别名
——
英文名称
N-methyl-(2-methyl-naphth-1-yl)-methylamine
英文别名
methyl-(2-methyl-naphthalen-1-ylmethyl)amine;N-methyl-1-(2-methylnaphthalen-1-yl)methanamine
N-methyl-(2-methyl-naphth-1-yl)-methylamine化学式
CAS
115600-31-2
化学式
C13H15N
mdl
——
分子量
185.269
InChiKey
ULITUMAPXUGAPU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY<br/>[FR] COMPOSES HETEROCYCLIQUES, PROCEDES DE PRODUCTION DE CEUX-CI ET UTILISATION DE CEUX-CI DANS UN TRAITEMENT
    申请人:AFFINIUM PHARM INC
    公开号:WO2004052890A1
    公开(公告)日:2004-06-24
    In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.
    在某种程度上,本发明涉及公式(I)的抗菌化合物,其中A是一个双环杂芳基环或三环环,R2是一个杂环残基;L是一个键,或者L是烷基,烯基或环烷基。
  • Naphthyl derivatives, pharmaceutical compositions containing these
    申请人:Dr. Karl Thomae GmbH
    公开号:US04871735A1
    公开(公告)日:1989-10-03
    The present invention relates to new naphthyl derivatives of general formula ##STR1## wherein N represents the number 1 or 2, A represents a --CH.sub.2 --, --CO--, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, ##STR2## while the atom marked with an x is linked to the phenyl nucleus, E represents a straight chained alkylene group optionally substituted by an alkyl group, G represents a straight chained alkylene group optionally substituted by an alkyl group, L represents a bond or an oxygen atom, if G represents a straight chained alkylene group with 2 to 5 carbon atoms optionally substituted by an alkyl group, R.sub.1 and R.sub.2, which may be identical or different, represent alkyl or alkoxy groups or R.sub.1 and R.sub.2 together represent an alkylenedioxy group, R.sub.3 represents a hydrogen atom, or an alkyl or an allyl group, R.sub.4, R.sub.5 and R.sub.6, which may be identical or different, represent hydrogen atoms, alkyl or alkoxy groups, the enantiomers and the acid addition salts thereof, which have valuable pharmacological properties, particularly a heart rate lowering activity. The new compounds may be prepared using methods known per se.
    本发明涉及一种新的萘基衍生物,其一般式为##STR1##其中N代表数字1或2,A代表--CH.sub.2 --,--CO--,--CH.sub.2 CH.sub.2 --,--CH.dbd.CH--,##STR2##而带有x标记的原子连接到苯环,E代表可选地被烷基取代的直链烷基,G代表可选地被烷基取代的直链烷基,L代表键或氧原子,如果G代表具有2至5个碳原子的可选地被烷基取代的直链烷基,则R.sub.1和R.sub.2,可以相同或不同,代表烷基或烷氧基,或R.sub.1和R.sub.2一起代表烷二醚基,R.sub.3代表氢原子,或烷基或烯丙基,R.sub.4,R.sub.5和R.sub.6可以相同或不同,代表氢原子,烷基或烷氧基,其对手异构体和酸加成盐具有有价值的药理特性,特别是心率降低活性。新化合物可以使用已知的方法制备。
  • Compositions comprising multiple bioactive agents, and methods of using the same
    申请人:Berman M. Judd
    公开号:US20060142265A1
    公开(公告)日:2006-06-29
    In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent.
    本发明的一部分涉及含有FabI抑制剂和至少一种其他生物活性剂的组合物。另一部分,本发明涉及含有I-III式化合物和至少一种其他抗菌剂的抗菌组合物。
  • Heterocyclic compounds, methods of making them and their use in therapy
    申请人:Berman Judd
    公开号:US20060183908A1
    公开(公告)日:2006-08-17
    In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R 2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.
    部分地,本发明涉及公式(I)中的抗菌化合物,其中A是双环杂芳基环或三环环,并且R2是杂环残基; L是键合或L是烷基,烯基或环烷基。
  • Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy
    申请人:Berman Judd
    公开号:US20110124633A1
    公开(公告)日:2011-05-26
    In part, the present invention is directed to antibacterial compounds.
    部分地,本发明涉及抗菌化合物。
查看更多